Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2006-11-20
2009-11-10
Nickol, Gary B. (Department: 1648)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S214100
Reexamination Certificate
active
07615209
ABSTRACT:
The present invention discloses methods for inducing regression of a tumor in a subject by administering a pharmaceutical composition comprising a lentogenic strain of Newcastle disease virus (NDV). A preferred viral strain of NDV for inducing regression of a tumor in a subject is a clonal strain of NDV, the NDV HUJ. The methods of the present invention are particularly useful for inducing regression of tumors in patients unresponsive to conventional anti-cancer therapies.
REFERENCES:
patent: 5118502 (1992-06-01), Glisson et al.
patent: 5124148 (1992-06-01), Csatary et al.
patent: 5215745 (1993-06-01), Csatary et al.
patent: 5602023 (1997-02-01), Csatary
patent: 5733556 (1998-03-01), Schrier et al.
patent: 5762938 (1998-06-01), Paoletti et al.
patent: 6464984 (2002-10-01), Audonnet et al.
patent: 6719979 (2004-04-01), Peeters et al.
patent: 7056689 (2006-06-01), Lorence et al.
patent: 7122182 (2006-10-01), Groene et al.
patent: 2003/0044384 (2003-03-01), Roberts et al.
patent: 2003/0077819 (2003-04-01), Groene et al.
Csatary, L.K., “Viruses in the treatment of cancer,” Lancet (1971) 2:825.
Freeman, A.I., “Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme,” Molecular Therapy (2006) 13:221-228.
Phuangsab, A., “Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration,” Cancer Letters (2001) 172:27-36.
Schirrmacher, V., “Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects,” Int J Oncol. (2001) 18(5):945-952.
Tzadok-David, Y., “The effect of a mesogenic and a lentogenic Newcastle disease virus strain on Burkitt lymphoma Daudi cells,” J Cancer Res Clin Oncol (1995) 121:169-174.
Freeman Arnold I.
Galun Eithan
Greenbaum Evgeniya
Irving Charles S.
Panet Amos
Li Bao Qun
Nickol Gary B.
Theravir Management L.P.
Winston & Strawn LLP
Yissum Research Development Company of the Hebrew University of
LandOfFree
Compositions of NDV and methods of use thereof for treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of NDV and methods of use thereof for treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of NDV and methods of use thereof for treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4059865